Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWise Group Regulatory News (WISE)

Share Price Information for Wise Group (WISE)

Share Price is delayed by 15 minutes
Get Live Data
828.00    2.00 (0.24%)
Bid:
828.00
Ask:
830.00
Spread: 2.00 (0.242%)
Market Cap: £8.28b
WISE Live PriceLast checked at - London Stock Exchange

Intraday Wise Group Share Chart

Establishment of Euro Medium Term Note Programme

13 Nov 2025 09:14

RNS Number : 4266H
Wise PLC
13 November 2025
Β 

Wise Financing plcΒ -Β LEI: 6488E9H7Z3K04JNN7302Wise plc - LEI: 213800LD9XCHIC1C4V71

Β 

THIS ANNOUNCEMENT IS NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OR IN ANY OTHER JURISDICTION IN WHICH OFFERS OR SALES WOULD BE PROHIBITED BY APPLICABLE LAW

Β 

Β 

13 November 2025

Β 

WISE FINANCING PLC

Β 

ESTABLISHMENT OF EURO MEDIUM TERM NOTE PROGRAMME AND PUBLICATION OF ADMISSION PARTICULARS

Β 

Β 

Wise Financing plc, a wholly-ownedΒ finance subsidiary of Wise Financial Holdings Limited (a wholly-owned subsidiary of Wise plc), today announces the establishment of its Euro Medium Term Note Programme (the "Programme").

Β 

As part of the Programme establishment, the following admission particulars (the "Admission Particulars") have been submitted to and approved by the International Securities Market of the London Stock Exchange:

Β 

Admission Particulars dated 13 November 2025 relating to the Euro Medium Term Note Programme of Wise Financing plc, as Issuer, which is unconditionally and irrevocably guaranteed by Wise plc, as Parent Guarantor, and certain of its subsidiaries.

Β 

A copy of the Admission Particulars can be viewed on Wise plc's website at https://wise.com/owners/debt-issuance.

Β 

This website is not provided for, or directed at, U.S. persons or persons in the United States. If you are a U.S. person or are viewing this page from the United States, you should exit this section of the website.

Β 

Enquiries

Martin Adams - Owner Relationsowners@wise.com

Sana Rahman - Communicationspress@wise.com

Brunswick GroupCharles Pretzlik / Emily Murphywise@brunswickgroup.com +44 (0) 20 7404 5959

Β 

About Wise

Β 

Wise is a global technology company, building the best way to move and manage the world's money.With Wise Account and Wise Business, people and businesses can hold 40 currencies, move money between countries and spend money abroad. Large companies and banks use Wise technology too; an entirely new network for the world's money. Launched in 2011, Wise is one of the world's fastest growing, profitable tech companies.

In fiscal year 2025, Wise supported around 15.6 million people and businesses, processing over $197 billion in cross-border transactions and saving customers around $2.7 billion.

Β 

DISCLAIMER - INTENDED ADDRESSES

Please note that the information contained in the Admission Particulars may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Admission Particulars) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Admission Particulars is not addressed. Prior to relying on the information contained in the Admission Particulars you must ascertain from the Admission Particulars whether or not you are part of the intended addressees of the information contained therein.

The Admission Particulars do not constitute an offer of securities for sale in the United States. The notes described herein and in the Admission Particulars have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or under any relevant securities laws of any state of the United States of America, and may not be offered or sold to U.S. persons or to persons within the United States of America (as such terms are defined in Regulation S under the Securities Act) , except pursuant to an exemption from the Securities Act. For a further description of certain restrictions on offers and sales of the notes and on distribution of the Admission Particulars, see the "Subscription and Sale" section in the Admission Particulars.

Your right to access this service is conditional upon complying with the above requirement.

No offer or invitation to acquire any securities is being made pursuant to this announcement.

END

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
MSCGCBDBDBBDGUX
Date   Source Headline
9th Sep 20227:00 amRNSHolding(s) in Company
8th Sep 20227:00 amRNSTotal Voting Rights
6th Sep 20229:41 amRNSPDMR Shareholding
31st Aug 202211:31 amRNSTotal Voting Rights
15th Aug 202211:00 amRNSNotice of AGM
4th Aug 202212:01 pmRNSDirector/PDMR Shareholding
1st Aug 20224:50 pmRNSHolding(s) in Company
1st Aug 202210:02 amRNSTotal Voting Rights
25th Jul 202210:39 amRNSPDMR Shareholding
20th Jul 20222:12 pmRNSHolding(s) in Company
20th Jul 202211:43 amRNSPDMR Shareholding
19th Jul 20227:00 amRNSWise Plc Q1 FY23 Trading Update
6th Jul 20221:00 pmRNS2022 Annual Report & notice Q1 FY23 trading update
1st Jul 20223:57 pmRNSTotal Voting Rights
28th Jun 20227:00 amRNSWise plc FY22 results for year ended 31 March 2022
27th Jun 20227:00 amRNSFCA Investigation
31st May 20224:25 pmRNSTotal Voting Rights
25th May 20222:11 pmRNSDirector/PDMR Shareholding
17th May 20221:57 pmRNSCFO Update
6th May 20223:46 pmRNSQ1 2022 Mission Update
5th May 202212:46 pmRNSDirector/PDMR Shareholding
20th Apr 20223:12 pmRNSDirector/PDMR Shareholding
20th Apr 20223:11 pmRNSDirector/PDMR Shareholding
5th Apr 202212:19 pmRNSDirector/PDMR Shareholding
1st Apr 20229:00 amRNSChange of Remuneration Committee Chair
18th Mar 202211:51 amRNSChanges to Committee Composition
24th Feb 20223:54 pmRNSAppointment of Interim CFO
24th Feb 20223:02 pmRNSDirectorate Change
2nd Feb 20221:21 pmRNSDirector/PDMR Shareholding
28th Jan 20224:47 pmRNSTotal Voting Rights
24th Jan 20229:20 amRNSDirector/PDMR Shareholding
19th Jan 20227:00 amRNSQ3 FY2022 Trading Update
4th Jan 202210:20 amRNSTotal Voting Rights
23rd Dec 20211:34 pmRNSDirector/PDMR Shareholding
17th Dec 202110:07 amRNSDirector/PDMR Shareholding
9th Dec 20219:11 amRNSChanges to Board and Committee Composition
1st Dec 20215:23 pmRNSTotal Voting Rights
30th Nov 20218:58 amRNSIssue of Equity
30th Nov 20217:00 amRNSHalf-year Report
29th Nov 20212:38 pmRNSHalf-year Report
29th Nov 20211:24 pmRNSHalf-year Report
26th Nov 20214:31 pmRNSHolding(s) in Company
25th Nov 20213:47 pmRNSRegulatory Approval
3rd Nov 20214:24 pmRNSDirector/PDMR Shareholding
26th Oct 202110:17 amRNSDirector/PDMR Shareholding
21st Oct 20214:43 pmRNSProposed secondary placing and loan of A shares
19th Oct 202112:05 pmRNSDirector/PDMR Shareholding
19th Oct 20217:00 amRNSQ2 Trading Update
8th Sep 20217:00 amRNSPublication of a Prospectus
7th Sep 20211:44 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.